RxDoctor Payments DataLook up a doctor →

Russell Butterfield

Neurology with Special Qualifications in Child Neurology · Salt Lake City, UTNPI 1639352321

Payments from drug & device makers

$7,482,315in general payments, 2019–2025

Across 763 payments — averaging $9806.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$2.7M
  • Pfizer$2.2M
  • Sarepta Therapeutics, Inc.$1.5M
  • Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$423K
  • PTC Therapeutics, Inc.$324K
  • Novartis$279K
  • plus $82K from 1 others
$40,370in research payments, 2019–2025

Across 31 payments — averaging $1302.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$40K

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen27$2,731,291
Pfizer114$2,189,603
Sarepta Therapeutics, Inc.461$1,452,272
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)77$423,440
PTC Therapeutics, Inc.39$324,499
Novartis22$279,442
Genentech, Inc.23$81,769

How this compares

$7,482,315 in reported general payments places this provider in the 95th percentile of 21 neurology with special qualifications in child neurology providers in Utah.

See all neurology with special qualifications in child neurology providers in Utah →

Other neurology with special qualifications in child neurology in Salt Lake City

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →